Literature DB >> 6415111

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

H W Murray, B Y Rubin, C D Rothermel.   

Abstract

We have found that the crude lymphokines, which prime the human monocyte-derived macrophage to generate H2O2 and exert microbicidal activity against intracellular Leishmania donovani, are rich in interferon (IFN)-gamma (600-3,000 U/ml). To determine the role of this specific lymphocyte product in macrophage activation, lymphokines were pretreated with a monoclonal antibody that neutralizes human IFN-gamma. Antibody exposure completely abolished the capacity of both mitogen- and antigen-stimulated lymphokines to either enhance macrophage H2O2 release or induce leishmanicidal activity. In addition, partially purified and pure recombinant human IFN-gamma were as effective as crude lymphokines in activating macrophages, and 3 d of treatment with 300 U/ml resulted in a seven- to eightfold increase in H2O2 generation and the intracellular killing of both L. donovani promastigotes and amastigotes. The ability of crude lymphokines to induce monocytes and macrophages from a patient with chronic granulomatous disease to kill L. donovani promastigotes was similarly abrogated by anti-IFN-gamma antibody, and could also be achieved by IFN-gamma alone. These results suggest that IFN-gamma is the key macrophage-activating molecule present within human lymphokines, and indicate that IFN-gamma can enhance both the oxygen-dependent and -independent antiprotozoal mechanisms of human mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415111      PMCID: PMC370435          DOI: 10.1172/JCI111107

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii).

Authors:  J S Remington; T C Merigan
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

2.  Suppression of intracellular multiplication of Mycobacterium tuberculosis by virus-inhibiting factor or interferon.

Authors:  K Mizunoe; M Hiraki; Y Nagano; N Maehara
Journal:  Jpn J Microbiol       Date:  1975-06

3.  The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon.

Authors:  B Y Rubin; A H Bartal; S L Anderson; S K Millet; Y Hirshaut; C Feit
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

4.  Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.

Authors:  H W Murray; H Masur; J S Keithly
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Production and properties of immune interferon from spleen cell cultures of Toxoplasma-infected mice.

Authors:  T Shirahata; K Shimizu
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

6.  Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.

Authors:  E M Carvalho; R S Teixeira; W D Johnson
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

7.  Production and properties of Toxoplasma growth inhibitory factor (Toxo-GIF) and interferon (IFN) in the lymphokines and the circulation of Toxoplasma immune mice.

Authors:  H Sakurai; Y Takei; Y Omata; N Suzuki
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1981-12

8.  Effect of Interferon and Interferon Inducers on Infections with a Nonviral Intracellular Microorganism, Rickettsia akari.

Authors:  J Kazar; P A Krautwurst; F B Gordon
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

9.  Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.

Authors:  T Kasahara; J J Hooks; S F Dougherty; J J Oppenheim
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

10.  Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products.

Authors:  J S Borges; W D Johnson
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  132 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Immunocytochemical analyses and targeted gene disruption of GTPBP1.

Authors:  S Senju; K Iyama; H Kudo; S Aizawa; Y Nishimura
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice.

Authors:  I Sugawara; H Yamada; H Kaneko; S Mizuno; K Takeda; S Akira
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway.

Authors:  I P Cerávolo; A C Chaves; C A Bonjardim; D Sibley; A J Romanha; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease.

Authors:  S G Reed; E M Carvalho; C H Sherbert; D P Sampaio; D M Russo; O Bacelar; D L Pihl; J M Scott; A Barral; K H Grabstein
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.

Authors:  I Suffia; B Ferrua; X Stien; B Mograbi; P Marty; D Rousseau; K Fragaki; J Kubar
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

7.  Oxidant generation by single infected monocytes after short-term fluorescence labeling of a protozoan parasite.

Authors:  Haeok K Chang; Colin Thalhofer; Breck A Duerkop; Joanna S Mehling; Shilpi Verma; Kenneth J Gollob; Roque Almeida; Mary E Wilson
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

8.  In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing.

Authors:  C J Morrison; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

9.  Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products.

Authors:  C D Kelly; C M Russo; B Y Rubin; H W Murray
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

10.  Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.

Authors:  G S Nabors; J P Farrell
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.